{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T12:27:07Z","timestamp":1793276827735,"version":"4.5.0"},"reference-count":200,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,2,19]],"date-time":"2015-02-19T00:00:00Z","timestamp":1424304000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["journal-of-hepatology.eu","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.jhep.2015.02.023","type":"journal-article","created":{"date-parts":[[2015,4,22]],"date-time":"2015-04-22T01:45:22Z","timestamp":1429667122000},"page":"S25-S37","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":485,"special_numbering":"S","title":["New paradigms in the treatment of hepatic cholestasis: From UDCA to FXR, PXR and beyond"],"prefix":"10.1016","volume":"62","author":[{"given":"Ulrich","family":"Beuers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Trauner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Jansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raoul","family":"Poupon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2015.02.023_b0005","series-title":"Gastroenterology in the 20th century","first-page":"267","article-title":"Bile \u2013 A historical review of studies on its form and function","author":"Beuers","year":"1994"},{"key":"10.1016\/j.jhep.2015.02.023_b0010","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1056\/NEJM199810223391707","article-title":"Molecular pathogenesis of cholestasis","volume":"339","author":"Trauner","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2015.02.023_b0015","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/clpt.2012.111","article-title":"Molecular targets for the treatment of fibrosing cholangiopathies","volume":"92","author":"Maillette de Buy Wenniger","year":"2012","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jhep.2015.02.023_b0020","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1476-5381.2008.00030.x","article-title":"Nuclear receptors as therapeutic targets in cholestatic liver diseases","volume":"156","author":"Zollner","year":"2009","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jhep.2015.02.023_b0025","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1016\/S0022-2275(20)34421-7","article-title":"Physicochemical properties of bile acids and their relationship to biological properties: an overview of the problem","volume":"25","author":"Hofmann","year":"1984","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jhep.2015.02.023_b0030","first-page":"690","article-title":"Dissolution of cholesterol gallstones by long-term administration of ursodeoxycholic acid","volume":"72","author":"Makino","year":"1975","journal-title":"Nippon Shokakibyo Gakkai Zasshi"},{"key":"10.1016\/j.jhep.2015.02.023_b0035","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/S0140-6736(87)91610-2","article-title":"Is ursodeoxycholic acid an effective treatment for primary biliary cirrhosis?","volume":"1","author":"Poupon","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2015.02.023_b0040","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/0016-5085(89)91698-3","article-title":"Ursodeoxycholic acid in primary biliary cirrhosis: results of a controlled double-blind trial","volume":"97","author":"Leuschner","year":"1989","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2015.02.023_b0045","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1056\/NEJM199105303242204","article-title":"A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group","volume":"324","author":"Poupon","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2015.02.023_b0050","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/hep.1840190314","article-title":"Predictive factors in ursodeoxycholic acid-treated patients with primary biliary cirrhosis: role of serum markers of connective tissue","volume":"19","author":"Poupon","year":"1994","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.02.023_b0055","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/S0016-5085(97)70183-5","article-title":"Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis","volume":"113","author":"Poupon","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2015.02.023_b0060","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1056\/NEJM199405123301903","article-title":"Ursodiol for the long-term treatment of primary biliary cirrhosis. The UDCA-PBC Study Group","volume":"330","author":"Poupon","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2015.02.023_b0065","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1002\/hep.510290603","article-title":"Ten-year survival in ursodeoxycholic acid-treated patients with primary biliary cirrhosis. The UDCA-PBC Study Group","volume":"29","author":"Poupon","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.02.023_b0070","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0168-8278(00)80216-0","article-title":"Long-term effects of ursodeoxycholic acid in primary biliary cirrhosis: results of a double-blind controlled multicentric trial. UDCA-Cooperative Group from the Spanish Association for the Study of the Liver","volume":"32","author":"Pares","year":"2000","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2015.02.023_b0075","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/hep.22906","article-title":"Primary biliary cirrhosis","volume":"50","author":"Lindor","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.02.023_b0080","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jhep.2009.04.009","article-title":"EASL Clinical Practice Guidelines: management of cholestatic liver diseases","volume":"51","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2015.02.023_b0085","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1053\/j.gastro.2004.11.009","article-title":"The effect of ursodeoxycholic acid therapy on the natural course of primary biliary cirrhosis","volume":"128","author":"Corpechot","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2015.02.023_b0090","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1053\/j.gastro.2014.08.029","article-title":"Levels of alkaline phosphatase and bilirubin are surrogate end points of outcomes of patients with primary biliary cirrhosis: an international follow-up study","volume":"147","author":"Lammers","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2015.02.023_b0095","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1053\/j.gastro.2005.12.029","article-title":"Excellent long-term survival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic Acid","volume":"130","author":"Pares","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2015.02.023_b0100","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1002\/hep.22428","article-title":"Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis","volume":"48","author":"Corpechot","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.02.023_b0105","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1053\/j.gastro.2009.01.003","article-title":"Improved prognosis of patients with primary biliary cirrhosis that have a biochemical response to ursodeoxycholic acid","volume":"136","author":"Kuiper","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2015.02.023_b0110","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.jhep.2009.11.027","article-title":"Primary biliary cirrhosis: a 2010 update","volume":"52","author":"Poupon","year":"2010","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2015.02.023_b0115","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.jhep.2011.04.012","article-title":"A major step towards effective treatment evaluation in primary biliary cirrhosis","volume":"55","author":"Beuers","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2015.02.023_b0120","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1111\/j.1872-034X.2009.00527.x","article-title":"Ursodeoxycholic acid in primary sclerosing cholangitis: meta-analysis of randomized controlled trials","volume":"39","author":"Shi","year":"2009","journal-title":"Hepatol Res"},{"key":"10.1016\/j.jhep.2015.02.023_b0125","first-page":"CD003626","article-title":"Bile acids for primary sclerosing cholangitis","author":"Poropat","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jhep.2015.02.023_b0130","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/hep.23082","article-title":"High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis","volume":"50","author":"Lindor","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.02.023_b0135","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/hep.23294","article-title":"Diagnosis and management of primary sclerosing cholangitis","volume":"51","author":"Chapman","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.02.023_b0140","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/ncpgasthep0521","article-title":"Drug insight: mechanisms and sites of action of ursodeoxycholic acid in cholestasis","volume":"3","author":"Beuers","year":"2006","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2015.02.023_b0145","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jhep.2012.02.014","article-title":"Effect of ursodeoxycholic acid on bile acid profiles and intestinal detoxification machinery in primary biliary cirrhosis and health","volume":"57","author":"Dilger","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2015.02.023_b0150","series-title":"Strategies for the treatment of hepatobiliary diseases","first-page":"44","article-title":"Hepatoprotective effect of ursodeoxycholate in experimental animals","author":"Kitani","year":"1990"},{"key":"10.1016\/j.jhep.2015.02.023_b0155","first-page":"G243","article-title":"Ursodeoxycholate mobilizes intracellular Ca2+ and activates phosphorylase a in isolated hepatocytes","volume":"264","author":"Bouscarel","year":"1993","journal-title":"Am J Physiol"},{"key":"10.1016\/j.jhep.2015.02.023_b0160","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/0016-5085(93)90433-D","article-title":"Effects of tauroursodeoxycholic acid on cytosolic Ca2+ signals in isolated rat hepatocytes","volume":"104","author":"Beuers","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2015.02.023_b0165","doi-asserted-by":"crossref","first-page":"2984","DOI":"10.1172\/JCI116921","article-title":"Tauroursodeoxycholic acid stimulates hepatocellular exocytosis and mobilizes extracellular Ca++ mechanisms defective in cholestasis","volume":"92","author":"Beuers","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhep.2015.02.023_b0170","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/0006-291X(90)90800-3","article-title":"Tauroursodeoxycholic acid inhibits the cytosolic Ca++ increase in human neutrophils stimulated by formyl-methionyl-leucyl-phenylalanine","volume":"171","author":"Beuers","year":"1990","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jhep.2015.02.023_b0175","first-page":"G300","article-title":"Ursodeoxycholic acid inhibits glucagon-induced cAMP formation in hamster hepatocytes: a role for PKC","volume":"268","author":"Bouscarel","year":"1995","journal-title":"Am J Physiol"},{"key":"10.1016\/j.jhep.2015.02.023_b0180","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1053\/gast.1996.v110.pm8613063","article-title":"Tauroursodeoxycholic acid activates protein kinase C in isolated rat hepatocytes","volume":"110","author":"Beuers","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2015.02.023_b0185","first-page":"G293","article-title":"Hepatocellular protein kinase C activation by bile acids: implications for regulation of cholesterol 7 alpha-hydroxylase","volume":"271","author":"Stravitz","year":"1996","journal-title":"Am J Physiol"},{"key":"10.1016\/j.jhep.2015.02.023_b0190","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1053\/gast.1997.v113.pm9322526","article-title":"Mitogen-activated protein kinases mediate the stimulation of bile acid secretion by tauroursodeoxycholate in rat liver","volume":"113","author":"Schliess","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2015.02.023_b0195","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1053\/gast.2001.26262","article-title":"Tauroursodesoxycholate-induced choleresis involves p38(MAPK) activation and translocation of the bile salt export pump in rats","volume":"121","author":"Kurz","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2015.02.023_b0200","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/S0016-5085(03)00274-9","article-title":"Involvement of integrins and Src in tauroursodeoxycholate-induced and swelling-induced choleresis","volume":"124","author":"Haussinger","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2015.02.023_b0205","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1002\/hep.25992","article-title":"Alpha5 beta1-integrins are sensors for tauroursodeoxycholic acid in hepatocytes","volume":"57","author":"Gohlke","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.02.023_b0210","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1042\/bj2910355","article-title":"Involvement of microtubules in the swelling-induced stimulation of transcellular taurocholate transport in perfused rat liver","volume":"291","author":"Haussinger","year":"1993","journal-title":"Biochem J"},{"key":"10.1016\/j.jhep.2015.02.023_b0215","doi-asserted-by":"crossref","first-page":"398","DOI":"10.2353\/ajpath.2006.050126","article-title":"Ca2+-dependent cytoprotective effects of ursodeoxycholic and tauroursodeoxycholic acid on the biliary epithelium in a rat model of cholestasis and loss of bile ducts","volume":"168","author":"Marzioni","year":"2006","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jhep.2015.02.023_b0220","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1053\/jhep.2001.24034","article-title":"Tauroursodeoxycholic acid inserts the apical conjugate export pump, Mrp2, into canalicular membranes and stimulates organic anion secretion by protein kinase C-dependent mechanisms in cholestatic rat liver","volume":"33","author":"Beuers","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.02.023_b0225","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1136\/gut.2007.140871","article-title":"Tauroursodeoxycholic acid exerts anticholestatic effects by a cooperative cPKC alpha-\/PKA-dependent mechanism in rat liver","volume":"57","author":"Wimmer","year":"2008","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2015.02.023_b0230","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/hep.23625","article-title":"Regulation of multidrug resistance-associated protein 2 by calcium signaling in mouse liver","volume":"52","author":"Cruz","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.02.023_b0235","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1002\/hep.23810","article-title":"The biliary HCO3\u2212 umbrella","volume":"52","author":"Beuers","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.02.023_b0240","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/hep.24691","article-title":"A biliary HCO3\u2212 umbrella constitutes a protective mechanism against bile acid-induced injury in human cholangiocytes","volume":"55","author":"Hohenester","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.02.023_b0245","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0016-5085(99)70564-0","article-title":"Assessment of biliary bicarbonate secretion in humans by positron emission tomography","volume":"117","author":"Prieto","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2015.02.023_b0250","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/0016-5085(93)90735-U","article-title":"Abnormal expression of anion exchanger genes in primary biliary cirrhosis","volume":"105","author":"Prieto","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2015.02.023_b0255","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/hep.510250104","article-title":"Decreased anion exchanger 2 immunoreactivity in the liver of patients with primary biliary cirrhosis","volume":"25","author":"Medina","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.02.023_b0260","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/hep.1840150409","article-title":"Effect of ursodeoxycholic acid on the kinetics of the major hydrophobic bile acids in health and in chronic cholestatic liver disease","volume":"15","author":"Beuers","year":"1992","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.02.023_b0265","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.gastro.2005.05.009","article-title":"Complementary stimulation of hepatobiliary transport and detoxification systems by rifampicin and ursodeoxycholic acid in humans","volume":"129","author":"Marschall","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2015.02.023_b0270","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0168-8278(98)80208-0","article-title":"Effect of tauroursodeoxycholic acid on bile-acid-induced apoptosis and cytolysis in rat hepatocytes","volume":"28","author":"Benz","year":"1998","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2015.02.023_b0275","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0168-8278(01)00092-7","article-title":"Ursodeoxycholic acid \u2018mechanisms of action and clinical use in hepatobiliary disorders\u2019","volume":"35","author":"Lazaridis","year":"2001","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2015.02.023_b0280","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1172\/JCI1325","article-title":"A novel role for ursodeoxycholic acid in inhibiting apoptosis by modulating mitochondrial membrane perturbation","volume":"101","author":"Rodrigues","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhep.2015.02.023_b0285","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/0006-291X(92)91146-H","article-title":"Ursodeoxycholic acid-dependent activation of the glucocorticoid receptor","volume":"188","author":"Tanaka","year":"1992","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jhep.2015.02.023_b0290","doi-asserted-by":"crossref","first-page":"47371","DOI":"10.1074\/jbc.M107098200","article-title":"Functional modulation of the glucocorticoid receptor and suppression of NF-kappaB-dependent transcription by ursodeoxycholic acid","volume":"276","author":"Miura","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2015.02.023_b0295","doi-asserted-by":"crossref","first-page":"G427","DOI":"10.1152\/ajpgi.00205.2012","article-title":"Glucocorticoid receptor-dependent immunomodulatory effect of ursodeoxycholic acid on liver lymphocytes in mice","volume":"305","author":"Takigawa","year":"2013","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jhep.2015.02.023_b0300","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.4049\/jimmunol.156.4.1601","article-title":"Ligand-independent activation of the glucocorticoid receptor by ursodeoxycholic acid. Repression of IFN-gamma-induced MHC class II gene expression via a glucocorticoid receptor-dependent pathway","volume":"156","author":"Tanaka","year":"1996","journal-title":"J Immunol"},{"key":"10.1016\/j.jhep.2015.02.023_b0305","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1002\/hep.20870","article-title":"Nuclear translocation of UDCA by the glucocorticoid receptor is required to reduce TGF-beta1-induced apoptosis in rat hepatocytes","volume":"42","author":"Sola","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.02.023_b0310","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1194\/jlr.R049437","article-title":"Key discoveries in bile acid chemistry and biology and their clinical applications: history of the last eight decades","volume":"55","author":"Hofmann","year":"2014","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jhep.2015.02.023_b0315","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1002\/hep.20943","article-title":"Novel biotransformation and physiological properties of norursodeoxycholic acid in humans","volume":"42","author":"Hofmann","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.02.023_b0320","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1002\/hep.510260218","article-title":"Effect of side chain length on biotransformation, hepatic transport, and choleretic properties of chenodeoxycholyl homologues in the rodent: studies with dinorchenodeoxycholic acid, norchenodeoxycholic acid, and chenodeoxycholic acid","volume":"26","author":"Yeh","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.02.023_b0325","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/0016-5085(86)90859-0","article-title":"Effect of side-chain shortening on the physiologic properties of bile acids: hepatic transport and effect on biliary secretion of 23-nor-ursodeoxycholate in rodents","volume":"90","author":"Yoon","year":"1986","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2015.02.023_b0330","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/0016-5085(80)90078-5","article-title":"Hypercholeresis induced by ursodeoxycholic acid and 7-ketolithocholic acid in the rat: possible role of bicarbonate transport","volume":"79","author":"Dumont","year":"1980","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2015.02.023_b0335","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1007\/s10354-008-0592-1","article-title":"Lessons from the toxic bile concept for the pathogenesis and treatment of cholestatic liver diseases","volume":"158","author":"Trauner","year":"2008","journal-title":"Wien Med Wochenschr"},{"key":"10.1016\/j.jhep.2015.02.023_b0340","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1053\/j.gastro.2005.10.018","article-title":"24-norUrsodeoxycholic acid is superior to ursodeoxycholic acid in the treatment of sclerosing cholangitis in Mdr2 (Abcb4) knockout mice","volume":"130","author":"Fickert","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2015.02.023_b0345","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1002\/hep.22891","article-title":"Side chain structure determines unique physiologic and therapeutic properties of norursodeoxycholic acid in Mdr2\u2212\/\u2212 mice","volume":"49","author":"Halilbasic","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.02.023_b0350","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/j.jhep.2013.01.026","article-title":"Differential effects of norUDCA and UDCA in obstructive cholestasis in mice","volume":"58","author":"Fickert","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2015.02.023_b0355","doi-asserted-by":"crossref","first-page":"e112","DOI":"10.1053\/j.gastro.2011.09.051","article-title":"Alterations in lipid metabolism mediate inflammation, fibrosis, and proliferation in a mouse model of chronic cholestatic liver injury","volume":"142","author":"Moustafa","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2015.02.023_b0360","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1002\/hep.23911","article-title":"Conjugation is essential for the anticholestatic effect of NorUrsodeoxycholic acid in taurolithocholic acid-induced cholestasis in rat liver","volume":"52","author":"Denk","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.02.023_b0365","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1159\/000360517","article-title":"Therapeutic role of bile acids and nuclear receptor agonists in fibrosing cholangiopathies","volume":"32","author":"Trauner","year":"2014","journal-title":"Dig Dis"},{"key":"10.1016\/j.jhep.2015.02.023_b0370","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1055\/s-2006-960172","article-title":"MDR3 (ABCB4) defects: a paradigm for the genetics of adult cholestatic syndromes","volume":"27","author":"Trauner","year":"2007","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jhep.2015.02.023_b0375","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/0092-8674(95)90530-8","article-title":"Identification of a nuclear receptor that is activated by farnesol metabolites","volume":"81","author":"Forman","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.jhep.2015.02.023_b0380","first-page":"72","article-title":"Isolation of proteins that interact specifically with the retinoid X receptor: two novel orphan receptors","volume":"9","author":"Seol","year":"1995","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.jhep.2015.02.023_b0385","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1126\/science.284.5418.1362","article-title":"Identification of a nuclear receptor for bile acids","volume":"284","author":"Makishima","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.jhep.2015.02.023_b0390","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1128\/MCB.14.3.1544","article-title":"A new orphan member of the nuclear hormone receptor superfamily that interacts with a subset of retinoic acid response elements","volume":"14","author":"Baes","year":"1994","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.jhep.2015.02.023_b0395","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1126\/science.1070477","article-title":"Vitamin D receptor as an intestinal bile acid sensor","volume":"296","author":"Makishima","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.jhep.2015.02.023_b0400","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1038\/sj.emboj.7601049","article-title":"Endocrine functions of bile acids","volume":"25","author":"Houten","year":"2006","journal-title":"EMBO J"},{"key":"10.1016\/j.jhep.2015.02.023_b0405","doi-asserted-by":"crossref","first-page":"e1000181","DOI":"10.1371\/journal.pbio.1000181","article-title":"REV-ERBalpha participates in circadian SREBP signaling and bile acid homeostasis","volume":"7","author":"Le Martelot","year":"2009","journal-title":"PLoS Biol"},{"key":"10.1016\/j.jhep.2015.02.023_b0410","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1053\/j.gastro.2008.05.035","article-title":"Regulation of bile acid synthesis by the nuclear receptor Rev-erbalpha","volume":"135","author":"Duez","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2015.02.023_b0415","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S1097-2765(00)80348-2","article-title":"Endogenous bile acids are ligands for the nuclear receptor FXR\/BAR","volume":"3","author":"Wang","year":"1999","journal-title":"Mol Cell"},{"key":"10.1016\/j.jhep.2015.02.023_b0420","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S1097-2765(00)00051-4","article-title":"A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis","volume":"6","author":"Goodwin","year":"2000","journal-title":"Mol Cell"},{"key":"10.1016\/j.jhep.2015.02.023_b0425","doi-asserted-by":"crossref","first-page":"28857","DOI":"10.1074\/jbc.M011610200","article-title":"Human bile salt export pump promoter is transactivated by the farnesoid X receptor\/bile acid receptor","volume":"276","author":"Ananthanarayanan","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2015.02.023_b0430","doi-asserted-by":"crossref","first-page":"G1124","DOI":"10.1152\/ajpgi.00539.2005","article-title":"Upregulation of a basolateral FXR-dependent bile acid efflux transporter OSTalpha-OSTbeta in cholestasis in humans and rodents","volume":"290","author":"Boyer","year":"2006","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jhep.2015.02.023_b0435","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1161\/01.ATV.0000178994.21828.a7","article-title":"The Farnesoid X receptor: a molecular link between bile acid and lipid and glucose metabolism","volume":"25","author":"Claudel","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jhep.2015.02.023_b0440","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.cmet.2005.09.001","article-title":"Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis","volume":"2","author":"Inagaki","year":"2005","journal-title":"Cell Metab"},{"key":"10.1016\/j.jhep.2015.02.023_b0445","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1172\/JCI21025","article-title":"Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c","volume":"113","author":"Watanabe","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhep.2015.02.023_b0450","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.cmet.2005.08.010","article-title":"The orphan nuclear receptor SHP regulates PGC-1alpha expression and energy production in brown adipocytes","volume":"2","author":"Wang","year":"2005","journal-title":"Cell Metab"},{"key":"10.1016\/j.jhep.2015.02.023_b0455","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1210\/me.2006-0224","article-title":"Orphan receptor small heterodimer partner is an important mediator of glucose homeostasis","volume":"20","author":"Wang","year":"2006","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.jhep.2015.02.023_b0460","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1101\/gad.184788.111","article-title":"Endocrine fibroblast growth factors 15\/19 and 21: from feast to famine","volume":"26","author":"Potthoff","year":"2012","journal-title":"Genes Dev"},{"key":"10.1016\/j.jhep.2015.02.023_b0465","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1002\/hep.25929","article-title":"Emerging role of fibroblast growth factors 15\/19 and 21 as metabolic integrators in the liver","volume":"56","author":"Cicione","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.02.023_b0470","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.cmet.2007.05.003","article-title":"Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21","volume":"5","author":"Inagaki","year":"2007","journal-title":"Cell Metab"},{"key":"10.1016\/j.jhep.2015.02.023_b0475","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.tem.2014.10.002","article-title":"Tissue-specific actions of the metabolic hormones FGF15\/19 and FGF21","volume":"26","author":"Owen","year":"2015","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.jhep.2015.02.023_b0480","doi-asserted-by":"crossref","first-page":"10023","DOI":"10.1074\/jbc.M808818200","article-title":"Fibroblast growth factor-19, a novel factor that inhibits hepatic fatty acid synthesis","volume":"284","author":"Bhatnagar","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2015.02.023_b0485","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1126\/science.1198363","article-title":"FGF19 as a postprandial, insulin-independent activator of hepatic protein and glycogen synthesis","volume":"331","author":"Kir","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.jhep.2015.02.023_b0490","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.cmet.2011.03.019","article-title":"FGF15\/19 regulates hepatic glucose metabolism by inhibiting the CREB-PGC-1alpha pathway","volume":"13","author":"Potthoff","year":"2011","journal-title":"Cell Metab"},{"key":"10.1016\/j.jhep.2015.02.023_b0495","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1194\/jlr.M700330-JLR200","article-title":"Differential regulation of bile acid homeostasis by the farnesoid X receptor in liver and intestine","volume":"48","author":"Kim","year":"2007","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jhep.2015.02.023_b0500","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1053\/j.gastro.2011.10.028","article-title":"Selective activation of nuclear bile acid receptor FXR in the intestine protects mice against cholestasis","volume":"142","author":"Modica","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2015.02.023_b0505","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.cmet.2014.05.020","article-title":"Cytoplasmic tyrosine phosphatase Shp2 coordinates hepatic regulation of bile acid and FGF15\/19 signaling to repress bile acid synthesis","volume":"20","author":"Li","year":"2014","journal-title":"Cell Metab"},{"key":"10.1016\/j.jhep.2015.02.023_b0510","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.cmet.2007.05.002","article-title":"Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states","volume":"5","author":"Badman","year":"2007","journal-title":"Cell Metab"},{"key":"10.1016\/j.jhep.2015.02.023_b0515","doi-asserted-by":"crossref","first-page":"12553","DOI":"10.1073\/pnas.1006962107","article-title":"Fibroblast growth factor 21 regulates energy metabolism by activating the AMPK-SIRT1-PGC-1alpha pathway","volume":"107","author":"Chau","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2015.02.023_b0520","doi-asserted-by":"crossref","first-page":"4057","DOI":"10.2337\/db14-0595","article-title":"Circulating FGF21 is liver derived and enhances glucose uptake during refeeding and overfeeding","volume":"63","author":"Markan","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.jhep.2015.02.023_b0525","doi-asserted-by":"crossref","first-page":"10853","DOI":"10.1073\/pnas.0904187106","article-title":"FGF21 induces PGC-1alpha and regulates carbohydrate and fatty acid metabolism during the adaptive starvation response","volume":"106","author":"Potthoff","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2015.02.023_b0530","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.cmet.2013.03.019","article-title":"An FGF21-adiponectin-ceramide axis controls energy expenditure and insulin action in mice","volume":"17","author":"Holland","year":"2013","journal-title":"Cell Metab"},{"key":"10.1016\/j.jhep.2015.02.023_b0535","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.cmet.2013.04.005","article-title":"Adiponectin mediates the metabolic effects of FGF21 on glucose homeostasis and insulin sensitivity in mice","volume":"17","author":"Lin","year":"2013","journal-title":"Cell Metab"},{"key":"10.1016\/j.jhep.2015.02.023_b0540","doi-asserted-by":"crossref","first-page":"3569","DOI":"10.1021\/jm025529g","article-title":"6alpha-ethyl-chenodeoxycholic acid (6-ECDCA), a potent and selective FXR agonist endowed with anticholestatic activity","volume":"45","author":"Pellicciari","year":"2002","journal-title":"J Med Chem"},{"key":"10.1016\/j.jhep.2015.02.023_b0545","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1124\/jpet.112.196519","article-title":"Synthetic farnesoid X receptor agonists induce high-density lipoprotein-mediated transhepatic cholesterol efflux in mice and monkeys and prevent atherosclerosis in cholesteryl ester transfer protein transgenic low-density lipoprotein receptor (\u2212\/\u2212) mice","volume":"343","author":"Hambruch","year":"2012","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jhep.2015.02.023_b0550","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1021\/jm8014124","article-title":"Discovery of XL335 (WAY-362450), a highly potent, selective, and orally active agonist of the farnesoid X receptor (FXR)","volume":"52","author":"Flatt","year":"2009","journal-title":"J Med Chem"},{"key":"10.1016\/j.jhep.2015.02.023_b0555","doi-asserted-by":"crossref","first-page":"5337","DOI":"10.1073\/pnas.0710981105","article-title":"Identification of a potent synthetic FXR agonist with an unexpected mode of binding and activation","volume":"105","author":"Soisson","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2015.02.023_b0560","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/j.bmcl.2010.12.089","article-title":"Conformationally constrained farnesoid X receptor (FXR) agonists: heteroaryl replacements of the naphthalene","volume":"21","author":"Bass","year":"2011","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.jhep.2015.02.023_b0565","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2014.12.005","article-title":"Efficacy of obeticholic acid in patients with primary biliary cirrhosis and inadequate response to ursodeoxycholic acid","author":"Hirschfield","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2015.02.023_b0570","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nrgastro.2013.151","article-title":"Bile acid receptors as targets for drug development","volume":"11","author":"Schaap","year":"2014","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2015.02.023_b0575","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/hep.26909","article-title":"Pruritus in cholestasis: facts and fiction","volume":"60","author":"Beuers","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.02.023_b0580","doi-asserted-by":"crossref","first-page":"247ra100","DOI":"10.1126\/scitranslmed.3009098","article-title":"A nontumorigenic variant of FGF19 treats cholestatic liver diseases","volume":"6","author":"Luo","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jhep.2015.02.023_b0585","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1016\/S0002-9440(10)61177-7","article-title":"A mouse model of hepatocellular carcinoma: ectopic expression of fibroblast growth factor 19 in skeletal muscle of transgenic mice","volume":"160","author":"Nicholes","year":"2002","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jhep.2015.02.023_b0590","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/S0006-291X(02)02550-0","article-title":"Identification of membrane-type receptor for bile acids (M-BAR)","volume":"298","author":"Maruyama","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jhep.2015.02.023_b0595","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1021\/jm7015864","article-title":"Novel potent and selective bile acid derivatives as TGR5 agonists: biological screening, structure-activity relationships, and molecular modeling studies","volume":"51","author":"Sato","year":"2008","journal-title":"J Med Chem"},{"key":"10.1016\/j.jhep.2015.02.023_b0600","doi-asserted-by":"crossref","first-page":"9435","DOI":"10.1074\/jbc.M209706200","article-title":"A G protein-coupled receptor responsive to bile acids","volume":"278","author":"Kawamata","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2015.02.023_b0605","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1677\/joe.1.06546","article-title":"Targeted disruption of G protein-coupled bile acid receptor 1 (Gpbar1\/M-Bar) in mice","volume":"191","author":"Maruyama","year":"2006","journal-title":"J Endocrinol"},{"key":"10.1016\/j.jhep.2015.02.023_b0610","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1002\/hep.23032","article-title":"The membrane-bound bile acid receptor TGR5 is localized in the epithelium of human gallbladders","volume":"50","author":"Keitel","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.02.023_b0615","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1042\/BJ20060537","article-title":"Targeted deletion of Gpbar1 protects mice from cholesterol gallstone formation","volume":"398","author":"Vassileva","year":"2006","journal-title":"Biochem J"},{"key":"10.1016\/j.jhep.2015.02.023_b0620","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.bbrc.2008.04.171","article-title":"Expression and function of the bile acid receptor TGR5 in Kupffer cells","volume":"372","author":"Keitel","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jhep.2015.02.023_b0625","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/hep.21458","article-title":"The G-protein coupled bile salt receptor TGR5 is expressed in liver sinusoidal endothelial cells","volume":"45","author":"Keitel","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.02.023_b0630","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1515\/bc.2010.077","article-title":"The membrane-bound bile acid receptor TGR5 (Gpbar-1) is localized in the primary cilium of cholangiocytes","volume":"391","author":"Keitel","year":"2010","journal-title":"Biol Chem"},{"key":"10.1016\/j.jhep.2015.02.023_b0635","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1002\/hep.24525","article-title":"The G-Protein-coupled bile acid receptor, Gpbar1 (TGR5), negatively regulates hepatic inflammatory response through antagonizing nuclear factor kappa light-chain enhancer of activated B cells (NF-kappaB) in mice","volume":"54","author":"Wang","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.02.023_b0640","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.cmet.2011.11.006","article-title":"TGR5 activation inhibits atherosclerosis by reducing macrophage inflammation and lipid loading","volume":"14","author":"Pols","year":"2011","journal-title":"Cell Metab"},{"key":"10.1016\/j.jhep.2015.02.023_b0645","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1002\/hep.24525","article-title":"The G-protein coupled bile acid receptor Gpbar1 (TGR5) negatively regulates hepatic inflammatory response through antagonizing Nuclear Factor kappaB","volume":"54","author":"Wang","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.02.023_b0650","doi-asserted-by":"crossref","first-page":"e25637","DOI":"10.1371\/journal.pone.0025637","article-title":"The bile acid receptor GPBAR-1 (TGR5) modulates integrity of intestinal barrier and immune response to experimental colitis","volume":"6","author":"Cipriani","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2015.02.023_b0655","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1053\/j.gastro.2012.09.055","article-title":"The receptor TGR5 mediates the prokinetic actions of intestinal bile acids and is required for normal defecation in mice","volume":"144","author":"Alemi","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2015.02.023_b0660","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1111\/j.1365-2982.2010.01487.x","article-title":"Expression and function of the bile acid receptor GpBAR1 (TGR5) in the murine enteric nervous system","volume":"22","author":"Poole","year":"2010","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.jhep.2015.02.023_b0665","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1111\/nmo.12148","article-title":"The bile acid receptor, TGR5, regulates basal and cholinergic-induced secretory responses in rat colon","volume":"25","author":"Ward","year":"2013","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.jhep.2015.02.023_b0670","doi-asserted-by":"crossref","first-page":"G527","DOI":"10.1152\/ajpgi.00388.2012","article-title":"Activation of G protein-coupled bile acid receptor, TGR5, induces smooth muscle relaxation via both Epac- and PKA-mediated inhibition of RhoA\/Rho kinase pathway","volume":"304","author":"Rajagopal","year":"2013","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jhep.2015.02.023_b0675","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1002\/hep.26463","article-title":"The receptor TGR5 protects the liver from bile acid overload during liver regeneration in mice","volume":"58","author":"Pean","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.02.023_b0680","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.1113\/jphysiol.2010.192146","article-title":"Hydrophobic bile salts inhibit gallbladder smooth muscle function via stimulation of GPBAR1 receptors and activation of KATP channels","volume":"588","author":"Lavoie","year":"2010","journal-title":"J Physiol"},{"key":"10.1016\/j.jhep.2015.02.023_b0685","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.jhep.2010.07.012","article-title":"Immediate neuroendocrine signaling after partial hepatectomy through acute portal hyperpressure and cholestasis","volume":"54","author":"Doignon","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2015.02.023_b0690","doi-asserted-by":"crossref","first-page":"e12403","DOI":"10.1371\/journal.pone.0012403","article-title":"Mutational characterization of the bile acid receptor TGR5 in primary sclerosing cholangitis","volume":"5","author":"Hov","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2015.02.023_b0695","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1159\/000324138","article-title":"TGR5 sequence variation in primary sclerosing cholangitis","volume":"29","author":"Hov","year":"2011","journal-title":"Dig Dis"},{"key":"10.1016\/j.jhep.2015.02.023_b0700","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1002\/hep.24537","article-title":"Dual farnesoid X receptor\/TGR5 agonist INT-767 reduces liver injury in the Mdr2\u2212\/\u2212 (Abcb4\u2212\/\u2212) mouse cholangiopathy model by promoting biliary HCO output","volume":"54","author":"Baghdasaryan","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.02.023_b0705","doi-asserted-by":"crossref","first-page":"S197","DOI":"10.1016\/S0168-8278(14)60551-1","article-title":"Protective role of membrane bile acid receptor TGR5 (GPBAR1) in DDC-induced sclerosing cholngitis in mice","volume":"60","author":"Baghdasaryan","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2015.02.023_b0710","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1053\/j.gastro.2009.10.052","article-title":"Biliary acute pancreatitis in mice is mediated by the G-protein-coupled cell surface bile acid receptor Gpbar1","volume":"138","author":"Perides","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2015.02.023_b0715","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1002\/glia.21049","article-title":"The bile acid receptor TGR5 (Gpbar-1) acts as a neurosteroid receptor in brain","volume":"58","author":"Keitel","year":"2010","journal-title":"Glia"},{"key":"10.1016\/j.jhep.2015.02.023_b0720","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1002\/hep.23585","article-title":"Hypertrophic cardiomyopathy and dysregulation of cardiac energetics in a mouse model of biliary fibrosis","volume":"51","author":"Desai","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.02.023_b0725","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1172\/JCI64551","article-title":"The TGR5 receptor mediates bile acid-induced itch and analgesia","volume":"123","author":"Alemi","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhep.2015.02.023_b0730","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1053\/j.gastro.2014.08.042","article-title":"The bile acid receptor TGR5 activates the TRPA1 channel to induce itch in mice","volume":"147","author":"Lieu","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2015.02.023_b0735","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.bbrc.2007.07.001","article-title":"Bile acid-induced TGR5-dependent c-Jun-N terminal kinase activation leads to enhanced caspase 8 activation in hepatocytes","volume":"361","author":"Yang","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jhep.2015.02.023_b0740","doi-asserted-by":"crossref","first-page":"S574","DOI":"10.1016\/S0168-8278(13)61426-9","article-title":"The bile acid receptor TGR5 promotes cholangiocyte proliferation through a cSRC\u2013EGFR\u2013ERK signaling pathway","volume":"58","author":"Keitel","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2015.02.023_b0745","doi-asserted-by":"crossref","first-page":"G322","DOI":"10.1152\/ajpgi.00263.2012","article-title":"Expression of bile acid receptor TGR5 in gastric adenocarcinoma","volume":"304","author":"Cao","year":"2013","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jhep.2015.02.023_b0750","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.jhep.2014.10.039","article-title":"Molecular mechanism of PPARalpha action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease","volume":"62","author":"Pawlak","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2015.02.023_b0755","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1002\/hep.27297","article-title":"The transrepressive activity of peroxisome proliferator-activated receptor alpha is necessary and sufficient to prevent liver fibrosis in mice","volume":"60","author":"Pawlak","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.02.023_b0760","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1053\/gast.2003.50007","article-title":"Induction of hepatic ABC transporter expression is part of the PPARalpha-mediated fasting response in the mouse","volume":"124","author":"Kok","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2015.02.023_b0765","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1042\/bj20020981","article-title":"Peroxisome proliferator-activated receptor alpha (PPARalpha)-mediated regulation of multidrug resistance 2 (Mdr2) expression and function in mice","volume":"369","author":"Kok","year":"2003","journal-title":"Biochem J"},{"key":"10.1016\/j.jhep.2015.02.023_b0770","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.hepres.2004.08.015","article-title":"Multidrug resistance3 is in situ detected in the liver of patients with primary biliary cirrhosis, and induced in human hepatoma cells by bezafibrate","volume":"30","author":"Matsumoto","year":"2004","journal-title":"Hepatol Res"},{"key":"10.1016\/j.jhep.2015.02.023_b0775","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1194\/jlr.M400132-JLR200","article-title":"Bezafibrate stimulates canalicular localization of NBD-labeled PC in HepG2 cells by PPARalpha-mediated redistribution of ABCB4","volume":"45","author":"Shoda","year":"2004","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jhep.2015.02.023_b0780","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1002\/hep.26018","article-title":"Anticholestatic effects of bezafibrate in patients with primary biliary cirrhosis treated with ursodeoxycholic acid","volume":"57","author":"Honda","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.02.023_b0785","doi-asserted-by":"crossref","DOI":"10.1002\/hep.27744","article-title":"On fibrates and cholestasis: a review","author":"Ghonem","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.02.023_b0790","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/MOG.0000000000000056","article-title":"Fibrate treatment for primary biliary cirrhosis","volume":"30","author":"Cuperus","year":"2014","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.jhep.2015.02.023_b0795","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/hepr.12373","article-title":"Combination therapy of bezafibrate and ursodeoxycholic acid for primary biliary cirrhosis: a meta-analysis","volume":"45","author":"Zhang","year":"2015","journal-title":"Hepatol Res"},{"key":"10.1016\/j.jhep.2015.02.023_b0800","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/liv.12290","article-title":"Bezafibrate normalizes alkaline phosphatase in primary biliary cirrhosis patients with incomplete response to ursodeoxycholic acid","volume":"34","author":"Lens","year":"2014","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2015.02.023_b0805","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0022-2275(20)30141-3","article-title":"Regulation of xenobiotic and bile acid metabolism by the nuclear pregnane X receptor","volume":"43","author":"Kliewer","year":"2002","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jhep.2015.02.023_b0810","doi-asserted-by":"crossref","first-page":"12208","DOI":"10.1073\/pnas.95.21.12208","article-title":"Identification of a human nuclear receptor defines a new signaling pathway for CYP3A induction","volume":"95","author":"Bertilsson","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2015.02.023_b0815","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1073\/pnas.051551698","article-title":"The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity","volume":"98","author":"Staudinger","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2015.02.023_b0820","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1124\/jpet.107.124610","article-title":"Positive and negative regulation of human hepatic hydroxysteroid sulfotransferase (SULT2A1) gene transcription by rifampicin: roles of hepatocyte nuclear factor 4alpha and pregnane X receptor","volume":"323","author":"Fang","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jhep.2015.02.023_b0825","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1124\/dmd.32.3.340","article-title":"Human PXR variants and their differential effects on the regulation of human UDP-glucuronosyltransferase gene expression","volume":"32","author":"Gardner-Stephen","year":"2004","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.jhep.2015.02.023_b0830","article-title":"Characterization and treatment of persistent hepatocellular secretory failure","author":"van Dijk","year":"2014","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2015.02.023_b0835","doi-asserted-by":"crossref","first-page":"14581","DOI":"10.1074\/jbc.M010173200","article-title":"Nuclear receptor response elements mediate induction of intestinal MDR1 by rifampin","volume":"276","author":"Geick","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2015.02.023_b0840","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1074\/jbc.M109326200","article-title":"Regulation of multidrug resistance-associated protein 2 (ABCC2) by the nuclear receptors pregnane X receptor, farnesoid X-activated receptor, and constitutive androstane receptor","volume":"277","author":"Kast","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2015.02.023_b0845","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1124\/dmd.31.11.1296","article-title":"Induction of ABCC3 (MRP3) by pregnane X receptor activators","volume":"31","author":"Teng","year":"2003","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.jhep.2015.02.023_b0850","doi-asserted-by":"crossref","first-page":"11323","DOI":"10.1073\/pnas.0604772103","article-title":"Benefit of farnesoid X receptor inhibition in obstructive cholestasis","volume":"103","author":"Stedman","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2015.02.023_b0855","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1073\/pnas.0409794102","article-title":"Nuclear receptors constitutive androstane receptor and pregnane X receptor ameliorate cholestatic liver injury","volume":"102","author":"Stedman","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2015.02.023_b0860","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/sj.bjp.0707235","article-title":"Hepatoprotective role of PXR activation and MRP3 in cholic acid-induced cholestasis","volume":"151","author":"Teng","year":"2007","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jhep.2015.02.023_b0865","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/S0140-6736(89)91608-5","article-title":"Comparison of rifampicin with phenobarbitone for treatment of pruritus in biliary cirrhosis","volume":"1","author":"Bachs","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2015.02.023_b0870","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1016\/0016-5085(92)90335-V","article-title":"Effects of long-term rifampicin administration in primary biliary cirrhosis","volume":"102","author":"Bachs","year":"1992","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2015.02.023_b0875","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/hep.20568","article-title":"No relevant effect of ursodeoxycholic acid on cytochrome P450 3A metabolism in primary biliary cirrhosis","volume":"41","author":"Dilger","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.02.023_b0880","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/j.1478-3231.2006.01326.x","article-title":"Rifampin is safe for treatment of pruritus due to chronic cholestasis: a meta-analysis of prospective randomized-controlled trials","volume":"26","author":"Khurana","year":"2006","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2015.02.023_b0885","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1053\/j.gastro.2010.06.046","article-title":"Budesonide induces remission more effectively than prednisone in a controlled trial of patients with autoimmune hepatitis","volume":"139","author":"Manns","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2015.02.023_b0890","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1053\/j.gastro.2012.08.029","article-title":"Glucocorticoids promote hepatic cholestasis in mice by inhibiting the transcriptional activity of the farnesoid x receptor","volume":"143","author":"Lu","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2015.02.023_b0895","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1136\/gut.53.1.78","article-title":"Human ileal bile acid transporter gene ASBT (SLC10A2) is transactivated by the glucocorticoid receptor","volume":"53","author":"Jung","year":"2004","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2015.02.023_b0900","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.abb.2004.09.019","article-title":"Coordinate transcriptional regulation of bile acid homeostasis and drug metabolism","volume":"433","author":"Eloranta","year":"2005","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.jhep.2015.02.023_b0905","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1210\/me.2005-0159","article-title":"The human Na+-taurocholate cotransporting polypeptide gene is activated by glucocorticoid receptor and peroxisome proliferator-activated receptor-gamma coactivator-1alpha, and suppressed by bile acids via a small heterodimer partner-dependent mechanism","volume":"20","author":"Eloranta","year":"2006","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.jhep.2015.02.023_b0910","first-page":"695","article-title":"Combination of ursodeoxycholic acid and glucocorticoids upregulates the AE2 alternate promoter in human liver cells","volume":"118","author":"Arenas","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhep.2015.02.023_b0915","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/S0016-5085(99)70351-3","article-title":"Oral budesonide and ursodeoxycholic acid for treatment of primary biliary cirrhosis: results of a prospective double-blind trial","volume":"117","author":"Leuschner","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2015.02.023_b0920","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1002\/hep.20646","article-title":"Budesonide combined with UDCA to improve liver histology in primary biliary cirrhosis: a three-year randomized trial","volume":"41","author":"Rautiainen","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.02.023_b0925","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/hep.510310209","article-title":"Oral budesonide in the treatment of patients with primary biliary cirrhosis with a suboptimal response to ursodeoxycholic acid","volume":"31","author":"Angulo","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.02.023_b0930","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.gcb.2010.02.004","article-title":"Triple therapy with ursodeoxycholic acid, budesonide and mycophenolate mofetil in patients with features of severe primary biliary cirrhosis not responding to ursodeoxycholic acid alone","volume":"34","author":"Rabahi","year":"2010","journal-title":"Gastroenterol Clin Biol"},{"key":"10.1016\/j.jhep.2015.02.023_b0935","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1053\/jhep.2003.50266","article-title":"Pharmacokinetics and pharmacodynamic action of budesonide in early- and late-stage primary biliary cirrhosis","volume":"38","author":"Hempfling","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.02.023_b0940","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/nri2378","article-title":"Vitamin effects on the immune system: vitamins A and D take centre stage","volume":"8","author":"Mora","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jhep.2015.02.023_b0945","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1053\/j.gastro.2008.12.040","article-title":"Bile salts control the antimicrobial peptide cathelicidin through nuclear receptors in the human biliary epithelium","volume":"136","author":"D\u2019Aldebert","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2015.02.023_b0950","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1194\/jlr.M044420","article-title":"Intestinal CYP3A4 protects against lithocholic acid-induced hepatotoxicity in intestine-specific VDR-deficient mice","volume":"55","author":"Cheng","year":"2014","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jhep.2015.02.023_b0955","doi-asserted-by":"crossref","first-page":"14486","DOI":"10.1074\/jbc.M110.116004","article-title":"Regulation of bile acid synthesis by fat-soluble vitamins A and D","volume":"285","author":"Schmidt","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2015.02.023_b0960","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1136\/gut.2010.234666","article-title":"Vitamin D inhibits proliferation and profibrotic marker expression in hepatic stellate cells and decreases thioacetamide-induced liver fibrosis in rats","volume":"60","author":"Abramovitch","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2015.02.023_b0965","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s12072-014-9548-2","article-title":"Vitamin D modulates biliary fibrosis in ABCB4-deficient mice","volume":"8","author":"Hochrath","year":"2014","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jhep.2015.02.023_b0970","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.cell.2013.03.028","article-title":"A vitamin D receptor\/SMAD genomic circuit gates hepatic fibrotic response","volume":"153","author":"Ding","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.jhep.2015.02.023_b0975","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1007\/s00424-003-1130-z","article-title":"The sodium bile salt cotransport family SLC10","volume":"447","author":"Hagenbuch","year":"2004","journal-title":"Pflugers Arch"},{"key":"10.1016\/j.jhep.2015.02.023_b0980","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.cgh.2009.04.024","article-title":"A new mechanism for bile acid diarrhea: defective feedback inhibition of bile acid biosynthesis","volume":"7","author":"Walters","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2015.02.023_b0985","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1007\/s004249900226","article-title":"Deoxycholic acid (DOC) affects the transport properties of distal colon","volume":"439","author":"Mauricio","year":"2000","journal-title":"Pflugers Arch"},{"key":"10.1016\/j.jhep.2015.02.023_b0990","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/srep00430","article-title":"TGR5 potentiates GLP-1 secretion in response to anionic exchange resins","volume":"2","author":"Harach","year":"2012","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhep.2015.02.023_b0995","doi-asserted-by":"crossref","first-page":"G371","DOI":"10.1152\/ajpgi.00400.2012","article-title":"Colesevelam suppresses hepatic glycogenolysis by TGR5-mediated induction of GLP-1 action in DIO mice","volume":"304","author":"Potthoff","year":"2013","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jhep.2015.02.023_b1000","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1159\/000341123","article-title":"Primary sclerosing cholangitis: new approaches to diagnosis, surveillance and treatment","volume":"30","author":"Trauner","year":"2012","journal-title":"Dig Dis"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827815001336?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827815001336?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,9]],"date-time":"2023-08-09T13:40:14Z","timestamp":1691588414000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827815001336"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":200,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S0168827815001336"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2015.02.023","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New paradigms in the treatment of hepatic cholestasis: From UDCA to FXR, PXR and beyond","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2015.02.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2015 European Association for the Study of the Liver. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}